NICE rebuffs PCTs’ call to help identify more areas for savings

By Dave West2009-07-30T00:00:00

Andrew Dillon the chief executive of the National Institute for Health and Clinical Excellence has rejected calls to identify more drugs and treatments that should be used less - or not at all - ahead of NHS investment cuts.

The National Institute for Health and Clinical Excellence has rejected calls to identify more drugs and treatments that should be used less - or not at all - ahead of NHS investment cuts.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
10 expert briefings every fortnight (Premium only)
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

to HSJ

Already a subscriber? Sign into your account here